Literature DB >> 25452543

Digital rectal examination in primary care is important for early detection of prostate cancer: a retrospective cohort analysis study.

Anna Lucy Walsh1, Shane W Considine1, Arun Z Thomas1, Thomas H Lynch1, Rustom P Manecksha2.   

Abstract

BACKGROUND: Currently, there is no standardised screening for prostate cancer in Europe. Assessment of risk is opportunistically undertaken in consultation with the GP or urologist. Evaluation of the prostate gland consists of a prostate-specific antigen (PSA) serum level and a digital rectal examination (DRE) of the gland. DRE is an essential part of the assessment that can independently predict prostate cancer in the setting of a normal PSA level. AIM: To evaluate the clinical usefulness of the DRE in general practice and urology clinics, and to ascertain its positive predictive value and sensitivity. DESIGN AND
SETTING: A retrospective analysis study of a cohort of Irish men who underwent TRUS guided biopsy of the prostate in a single Irish tertiary referral centre, despite a normal PSA level. Patients were identified from a Rapid Access Prostate Clinic patient database. Pathological biopsy results were correlated with clinical DRE findings.
METHOD: Patient demographics, PSA levels, and DRE findings from a prospectively established database and hospital data systems from May 2009 to October 2013 were analysed.
RESULTS: Of 103 men referred over a 53-month period with a normal age-adjusted PSA level, 67% were referred on the basis of an abnormal DRE alone. Thirty-five per cent of males with a normal PSA had prostate cancer. DRE alone had a sensitivity and specificity of 81% and 40% respectively in diagnosing prostate cancer, with a positive predictive value of 42%. Seventy-six per cent of these men had high-grade disease.
CONCLUSION: DRE is a key part of the assessment for prostate cancer. It can independently identify patients at risk of prostate cancer, with a substantial proportion of these having clinically significant disease requiring treatment. This study reinforces the importance of DRE in the primary care setting in the assessment for prostate cancer. An abnormal DRE, even in the setting of a normal PSA level, necessitates referral. © British Journal of General Practice 2014.

Entities:  

Keywords:  digital rectal examination; opportunistic screening; primary care; prostate cancer

Mesh:

Substances:

Year:  2014        PMID: 25452543      PMCID: PMC4240151          DOI: 10.3399/bjgp14X682861

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  20 in total

1.  Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial.

Authors:  Ian M Thompson; Donna Pauler Ankerst; Chen Chi; Phyllis J Goodman; Catherine M Tangen; M Scott Lucia; Ziding Feng; Howard L Parnes; Charles A Coltman
Journal:  J Natl Cancer Inst       Date:  2006-04-19       Impact factor: 13.506

2.  Presentation and clinical course of patients ultimately succumbing to carcinoma of the prostate.

Authors:  I M Thompson; E J Zeidman
Journal:  Scand J Urol Nephrol       Date:  1991

3.  Interexaminer variability of digital rectal examination in detecting prostate cancer.

Authors:  D S Smith; W J Catalona
Journal:  Urology       Date:  1995-01       Impact factor: 2.649

4.  Age-specific reference ranges for serum PSA.

Authors:  J E Oesterling
Journal:  N Engl J Med       Date:  1996-08-01       Impact factor: 91.245

5.  Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower.

Authors:  Ian M Thompson; Donna Pauler Ankerst; Chen Chi; M Scott Lucia; Phyllis J Goodman; John J Crowley; Howard L Parnes; Charles A Coltman
Journal:  JAMA       Date:  2005-07-06       Impact factor: 56.272

6.  Digital rectal examination and prostate-specific antigen abnormalities at the time of prostate biopsy and biopsy outcomes, 1980 to 1997.

Authors:  R O Roberts; E J Bergstralh; M M Lieber; S J Jacobsen
Journal:  Urology       Date:  2000-11-01       Impact factor: 2.649

Review 7.  Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate.

Authors:  J E Oesterling
Journal:  J Urol       Date:  1991-05       Impact factor: 7.450

8.  Evaluation of the digital rectal examination as a screening test for prostate cancer. Rotterdam section of the European Randomized Study of Screening for Prostate Cancer.

Authors:  F H Schröder; P van der Maas; P Beemsterboer; A B Kruger; R Hoedemaeker; J Rietbergen; R Kranse
Journal:  J Natl Cancer Inst       Date:  1998-12-02       Impact factor: 13.506

9.  European randomized study of screening for prostate cancer--the Rotterdam pilot studies.

Authors:  F H Shröder; R A Damhuis; W J Kirkels; H J De Koning; R Kranse; H G Nus; B G Blijenberg
Journal:  Int J Cancer       Date:  1996-01-17       Impact factor: 7.396

10.  Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter.

Authors:  Ian M Thompson; Donna K Pauler; Phyllis J Goodman; Catherine M Tangen; M Scott Lucia; Howard L Parnes; Lori M Minasian; Leslie G Ford; Scott M Lippman; E David Crawford; John J Crowley; Charles A Coltman
Journal:  N Engl J Med       Date:  2004-05-27       Impact factor: 91.245

View more
  9 in total

1.  Exploring the Process of Cancer Care for Patients With Pre-Existing Mobility Disability.

Authors:  Nicole D Agaronnik; Areej El-Jawahri; Charlotta Lindvall; Lisa I Iezzoni
Journal:  JCO Oncol Pract       Date:  2020-12-22

2.  Actual Contribution of Free to Total PSA Ratio in Prostate Diseases Differentiation.

Authors:  Alden Prcic; Edin Begic; Mustafa Hiros
Journal:  Med Arch       Date:  2016-07-27

3.  Application of transrectal ultrasound-guided repeat needle biopsy in the diagnosis of prostate cancer in Chinese population: A retrospective study.

Authors:  Yi Wang; Xizhi Wang; Jiang Yu; Jun Ouyang; Weidong Shen; Yibin Zhou; Jianquan Hou; Duangai Wen; Jinxian Pu; Yuxi Shan; Boxin Xue
Journal:  J Res Med Sci       Date:  2016-09-01       Impact factor: 1.852

4.  Multivariable risk-based patient selection for prostate biopsy in a primary health care setting: referral rate and biopsy results from a urology outpatient clinic.

Authors:  Daniël F Osses; Arnout R Alberts; Gonny C F Bausch; Monique J Roobol
Journal:  Transl Androl Urol       Date:  2018-02

5.  The diagnostic test accuracy of rectal examination for prostate cancer diagnosis in symptomatic patients: a systematic review.

Authors:  Daniel Jones; Charlotte Friend; Andreas Dreher; Victoria Allgar; Una Macleod
Journal:  BMC Fam Pract       Date:  2018-06-02       Impact factor: 2.497

6.  Is it possible to automatically assess pretreatment digital rectal examination documentation using natural language processing? A single-centre retrospective study.

Authors:  Selen Bozkurt; Kathleen M Kan; Michelle K Ferrari; Daniel L Rubin; Douglas W Blayney; Tina Hernandez-Boussard; James D Brooks
Journal:  BMJ Open       Date:  2019-07-18       Impact factor: 2.692

7.  Does a screening digital rectal exam provide actionable clinical utility in patients with an elevated PSA and positive MRI?

Authors:  Courtney M Chang; Andrew G McIntosh; Daniel D Shapiro; John W Davis; John F Ward; Justin R Gregg
Journal:  BJUI Compass       Date:  2021-05-04

8.  Intrinsic Disorder of the BAF Complex: Roles in Chromatin Remodeling and Disease Development.

Authors:  Nashwa El Hadidy; Vladimir N Uversky
Journal:  Int J Mol Sci       Date:  2019-10-23       Impact factor: 5.923

9.  The awareness of women on prostate cancer: a mixed-methods systematic review protocol.

Authors:  Ebenezer Wiafe; Kofi Boamah Mensah; Adwoa Bemah Boamah Mensah; Varsha Bangalee; Frasia Oosthuizen
Journal:  Syst Rev       Date:  2020-11-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.